Analysis of Biochemical Markers in Sera of Patients with Febrile Disease During the Fall

  • Received : 2010.11.04
  • Accepted : 2010.11.10
  • Published : 2010.12.31

Abstract

We studied a comparison of the concentration of biochemical markers in sera of patients hospitalized with high fever (n=296) in Jeonbuk province during the last 2 years (2008 to 2009). The patients were divided into three patient groups of viral hemorrhagic fever (VHF) patient group tested positive for Hantavirus (n=53), leptospirosis (LEP) patient group tested positive for Leptospira interrogans (n=137) and scrub typhus (TSU) patient group tested positive for Orientia tsutsugamushi (n=106). We analyzed the concentration of ALP, AST, ALT, blood urea nitrogen, creatinine and glucose and compared the mean levels of them to normal range, the first sample and last sample. The frequencies of abnormal patient elevated above the upper limit of normal for ALP, AST and ALT were 18~43.4%, 78~97% and 62.3~92.7% in patient groups, and 24.5~47.4% (total protein) and 13.2~50.0% (albumin) of patients in patient groups had decreased below the lower limit of normal. The patients showed higher abnormal levels of glucose in patient groups were 58.5% (viral hemorrhagic fever patient group), 66.4% (leptospirosis patient group), 71.7% (scrub typhus patient group) and 66.9% (total patient group). There were significant difference between the first sample and the last sample in the mean levels of AST (decreased 22.2% in viral hemorrhagic fever patient group, 30.2% in leptospirosis patient group, 20.4% in scrub typhus patient group and 24.1% in total patient group), BUN (43.0% in viral hemorrhagic fever patient group, 41.6% in leptospirosis patient group, 47.4% in scrub typhus patient group and 43.0% in total patient group) and glucose (20.2% viral hemorrhagic fever patient group, 17.9% in leptospirosis patient group, 18.6% in scrub typhus patient group and 18.9% in total patient group) in the first sample and the last sample. According to these results, those diseases may cause liver damage and have high concentration of ALP, AST, ALT and glucose in blood even though the patients get out of the hospital.

Keywords

References

  1. Abdulkader RCRM. Acute renal failure in leptospirosis. Renal Fail. 1997. 19: 191-198. https://doi.org/10.3109/08860229709026275
  2. Ashford DA, Kaiser RM, Spiegel RA. Asymptomatic infection and risk factors for leptospirosis in Nicaragua. J Trop Med Hyg. 2000. 63: 249-254.
  3. Burtis CA, Ashwood ER. Tietz Fundamentals of Clinical Chemistry. 2006. pp. 2253-2318. Saunders Company. Philadelphia, USA.
  4. Chappel RJ, Goris M, Palmer MF, Hartskeerl RA. Impact of proficiency testing on results of the microscopic agglutination test for diagnosis of leptospirosis. J Clin Microbiol. 2004. 42: 5484-5488. https://doi.org/10.1128/JCM.42.12.5484-5488.2004
  5. Cracco C, Delafosse C, Baril L, Lefort Y, Morelot C, Derenne JP, Bricaire F, Similowski T. Multiple organ failure complicating probable scrub typhus. Clin Infect Dis. 2000. 31: 191-192. https://doi.org/10.1086/313906
  6. Dreisbach AW, Lertora JJ. The effect of chronic renal failure on hepatic drug metabolism and drug disposition. Semin Dial. 2003.16: 45-50. https://doi.org/10.1046/j.1525-139X.2003.03011.x
  7. Edwards CN, Nicholson GD, Hassell TA, Everard COR. Leptospirosis in Barbados: a clinical study. West Indian Med J. 1990. 39: 27-34.
  8. Engelgau MM, Narayan KM, Herman WH. Screening for type 2 diabetes. Diabetes Care 2000. 23: 1563-1580. https://doi.org/10.2337/diacare.23.10.1563
  9. Graber AL, Elasy TA, Quinn D, Wolff K, Brown A. Improving glycemic control in adults with diabetes mellitus: shared responsibility in primary care practices. South Med J. 2002. 95: 684-690.
  10. Gitlin N, Serio KM. Ischemic hepatitis: widening horizons. Am J Gastroenterol. 1992. 87: 831-836.
  11. Griner PF, Mayewski RJ, Mushlin AI, Greenland P. Selection and interpretation of diagnostic tests and procedures. Ann Intern Med. 1981. 94: 553-600.
  12. Han WK, Waikar SS, Johnson A, Betensky RA, Dent CL, Devarajan P. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 2008. 73: 863-869. https://doi.org/10.1038/sj.ki.5002715
  13. Kim CH, Park ST, Oh GG. Comparison of protein electrophoresis fraction in the leptospirosis patient serum. J Exp Biomed Sci. 2004. 10: 253-257.
  14. Kim HS, Jo KH, Kang SG, Cha MJ, Hwang HH. A clinical research of tsutsugamushi disease occurred in and around Jeoung-up in the autumn of 2000. J Korean Acad Fam Med. 2002. 23: 87-95.
  15. Kim YS, Yun HJ, Shim SK, Koo SH, Kim SY, Kim S. A comparative trial of a single dose of azithromycin versus doxycycline for the treatment of mild scrub typhus. Clin Infect Dis. 2004. 39: 1329-1335. https://doi.org/10.1086/425008
  16. Kruger DH, Ulricha R, Lundkvist AA. Hantavirus infections and their prevention. Microbes Infect. 2001. 3: 1129-1144. https://doi.org/10.1016/S1286-4579(01)01474-5
  17. Lazo M, Selvin E, Clark. Brief communication: clinical implications of short-term variability in liver function test results. Ann Intern Med JM. 2008. 148: 348-352. https://doi.org/10.7326/0003-4819-148-5-200803040-00005
  18. Lee JS, Lee JH, Park JK, Kim SU. A clinical study of 40 patients with tsutsugamushi disease in Chungcheong province. Korean J Derm. 1989. 27: 272-282.
  19. Levett PN. Leptospirosis. Clin Microbiol Rev. 2001. 14: 296-326. https://doi.org/10.1128/CMR.14.2.296-326.2001
  20. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999. 130: 461-470. https://doi.org/10.7326/0003-4819-130-6-199903160-00002
  21. Linderholm M, Elgh F. Clinical characteristics of Hantanvirus Infections on the Eurasian continent. Curr Top Microbiol Immunol. 2001. 256: 135-151. https://doi.org/10.1007/978-3-642-56753-7_8
  22. Mathai E, Lloyd G, Cherian T. Serological evidence for the continued presence of human rickettsiosis in Southern India. Ann Trop Med Parasitol. 2001. 95: 395-398. https://doi.org/10.1080/00034980120065804
  23. Memon MI, Memon MA. Hepatitis C: An epidemiological review. J Viral Hepat. 2002. 9: 84-100. https://doi.org/10.1046/j.1365-2893.2002.00329.x
  24. Munro-Faure AD, Andrew R, Missen GA, Mackay-Dick J. Scrub typhus in Korea. JR Army Med Corps. 1951. 97: 227-229.
  25. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007. 30: 753-759. https://doi.org/10.2337/dc07-9920
  26. Pichette V, Leblond FA. Drug metabolism in chronic renal failure. Curr Drug Metab. 2003. 4: 91-103. https://doi.org/10.2174/1389200033489532
  27. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2002. 48: 436-472.
  28. Schmaljohn CS, Hjelle B. Hantaviruses: a global disease problem. Emerg Infect Dis. 1997. 3: 95-104. https://doi.org/10.3201/eid0302.970202
  29. Sheehan M, Haythorn P. Predictive values of various liver function tests with respect to the diagnosis of liver disease. Clin Biochem. 1979. 12: 262-263. https://doi.org/10.1016/S0009-9120(79)80122-8
  30. Smadel JE. Epidemic hemorrhagic fever. Am J Publ Health Nations Health. 1953. 43: 1327-1330. https://doi.org/10.2105/AJPH.43.10.1327
  31. Song JW, Lee JE, Kim SH, Kee SH, Park KS, Baek LJ. Seroepidemiologic analysis of acute febrile illness in Korea during 1997-1998. J Bacteriol Virol. 2002. 32: 263-267.
  32. Thammakumpee K, Silpapojakul K, Borrirak B. Leptospirosis and its pulmonary complications. Respirology 2005. 10: 656-659. https://doi.org/10.1111/j.1440-1843.2005.00764.x
  33. Williams AL, Hoofuagle JH. Ratio of serum aspartate aminotransferase to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology 1988. 95: 734-739.